DCM Shriram International Limited slipped into a standalone net loss for FY26 after a hefty exceptional stamp duty charge linked to a major corporate restructuring deal wiped out profitability for the year.
The company reported a standalone net loss of ₹12.12 crore for the financial year ended March 31, 2026, compared to a restated profit of ₹62.12 crore in the previous fiscal. The sharp reversal was largely driven by an exceptional expense of ₹20.82 crore related to stamp duty payments for the transfer of land at Kota under a Composite Scheme of Arrangement.
Revenue from operations also witnessed a decline, falling to ₹464.94 crore from a restated ₹590.15 crore a year earlier, reflecting the impact of restructuring adjustments and changes arising from the scheme implementation.
The development comes after a major restructuring exercise involving DCM Shriram Industries Limited, DCM Shriram Fine Chemicals Limited, and Lily Commercial Private Limited. The National Company Law Tribunal approved the scheme in November 2025, with the arrangement becoming effective in December 2025.
As part of the restructuring, the rayon undertaking of DCM Shriram Industries was transferred to DCM Shriram International, resulting in net assets worth ₹224.95 crore being vested into the company. The transaction also led to the creation of a capital reserve exceeding ₹101 crore after the issuance of 870 lakh equity shares to shareholders of DCM Shriram Industries.
The fourth quarter also reflected the pressure from the exceptional charge. While the company posted a pre-exceptional quarterly profit before tax of ₹6.23 crore, the stamp duty expense pushed it into a pre-tax loss of ₹14.59 crore and a post-tax loss of ₹16.27 crore for the quarter ended March 2026.
On a consolidated basis, including associate company DCM Hyundai Limited, the company reported a net loss of ₹13.78 crore for FY26 against a restated consolidated profit of ₹63.05 crore in FY25. Despite the earnings setback, the board recommended a final dividend of ₹0.40 per share for FY26, signaling confidence in the company’s long-term restructuring strategy and operational stability.
The loss stands in sharp contrast to the broader performance of the larger DCM Shriram Limited group, which recently reported a 42% surge in FY26 profit driven by strong chemicals and downstream business growth.